Leucine supplementation differentially enhances pancreatic cancer growth in lean and overweight mice
- PMID: 24685128
- PMCID: PMC4392529
- DOI: 10.1186/2049-3002-2-6
Leucine supplementation differentially enhances pancreatic cancer growth in lean and overweight mice
Abstract
Background: The risk of pancreatic cancer, the 4th deadliest cancer for both men and women in the United States, is increased by obesity. Calorie restriction (CR) is a well-known dietary regimen that prevents or reverses obesity and suppresses tumorigenesis in a variety of animal models, at least in part via inhibition of mammalian target of rapamycin (mTOR) signaling. Branched-chain amino acids (BCAA), especially leucine, activate mTOR and enhance growth and proliferation of myocytes and epithelial cells, which is why leucine is a popular supplement among athletes. Leucine is also increasingly being used as a treatment for pancreatic cancer cachexia, but the effects of leucine supplementation on pancreatic tumor growth have not been elucidated.
Results: Supplementation with leucine increased pancreatic tumor growth in both lean (104 ± 17 mm3 versus 46 ± 13 mm3; P <0.05) and overweight (367 ± 45 mm3 versus 230 ± 39 mm3; P <0.01) mice, but tumor enhancement was associated with different biological outcomes depending on the diet. In the lean mice, leucine increased phosphorylation of mTOR and downstream effector S6 ribosomal protein, but in the overweight mice, leucine reduced glucose clearance and thus increased the amount of circulating glucose available to the tumor.
Conclusions: These findings show that leucine supplementation enhances tumor growth in both lean and overweight mice through diet-dependent effects in a murine model of pancreatic cancer, suggesting caution against the clinical use of leucine supplementation for the purposes of skeletal muscle enhancement in cachectic patients.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4392529/bin/2049-3002-2-6-1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4392529/bin/2049-3002-2-6-2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4392529/bin/2049-3002-2-6-3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4392529/bin/2049-3002-2-6-4.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4392529/bin/2049-3002-2-6-5.gif)
Similar articles
-
Rapamycin partially mimics the anticancer effects of calorie restriction in a murine model of pancreatic cancer.Cancer Prev Res (Phila). 2011 Jul;4(7):1041-51. doi: 10.1158/1940-6207.CAPR-11-0023. Epub 2011 May 18. Cancer Prev Res (Phila). 2011. PMID: 21593197 Free PMC article.
-
Diabetes and branched-chain amino acids: What is the link?J Diabetes. 2018 May;10(5):350-352. doi: 10.1111/1753-0407.12645. Epub 2018 Feb 13. J Diabetes. 2018. PMID: 29369529
-
Short- and long-term effects of leucine and branched-chain amino acid supplementation of a protein- and energy-reduced diet on muscle protein metabolism in neonatal pigs.Amino Acids. 2018 Jul;50(7):943-959. doi: 10.1007/s00726-018-2572-0. Epub 2018 May 4. Amino Acids. 2018. PMID: 29728917 Free PMC article.
-
Reviewing the Effects of L-Leucine Supplementation in the Regulation of Food Intake, Energy Balance, and Glucose Homeostasis.Nutrients. 2015 May 22;7(5):3914-37. doi: 10.3390/nu7053914. Nutrients. 2015. PMID: 26007339 Free PMC article. Review.
-
Leucine supplementation and intensive training.Sports Med. 1999 Jun;27(6):347-58. doi: 10.2165/00007256-199927060-00001. Sports Med. 1999. PMID: 10418071 Review.
Cited by
-
Leucine Supplementation Exacerbates Morbidity in Male but Not Female Mice with Colorectal Cancer-Induced Cachexia.Nutrients. 2023 Oct 27;15(21):4570. doi: 10.3390/nu15214570. Nutrients. 2023. PMID: 37960223 Free PMC article.
-
Unveiling the intricate causal nexus between pancreatic cancer and peripheral metabolites through a comprehensive bidirectional two-sample Mendelian randomization analysis.Front Mol Biosci. 2023 Oct 25;10:1279157. doi: 10.3389/fmolb.2023.1279157. eCollection 2023. Front Mol Biosci. 2023. PMID: 37954977 Free PMC article.
-
Dietary Manipulation of Amino Acids for Cancer Therapy.Nutrients. 2023 Jun 25;15(13):2879. doi: 10.3390/nu15132879. Nutrients. 2023. PMID: 37447206 Free PMC article. Review.
-
Standard Hypercaloric, Hyperproteic vs. Leucine-Enriched Oral Supplements in Patients with Cancer-Induced Sarcopenia, a Randomized Clinical Trial.Nutrients. 2023 Jun 12;15(12):2726. doi: 10.3390/nu15122726. Nutrients. 2023. PMID: 37375630 Free PMC article. Clinical Trial.
-
Arginine shortage induces replication stress and confers genotoxic resistance by inhibiting histone H4 translation and promoting PCNA polyubiquitination.bioRxiv [Preprint]. 2023 Feb 3:2023.01.31.526362. doi: 10.1101/2023.01.31.526362. bioRxiv. 2023. Update in: Cell Rep. 2023 Apr 25;42(4):112296. doi: 10.1016/j.celrep.2023.112296. PMID: 36778247 Free PMC article. Updated. Preprint.
References
-
- Silverman DT, Swanson CA, Gridley G, Wacholder S, Greenberg RS, Brown LM, Hayes RB, Swanson GM, Schoenberg JB, Pottern LM, Schwartz AG, Fraumeni JF Jr, Hoover RN. Dietary and nutritional factors and pancreatic cancer: a case–control study based on direct interviews. J Natl Cancer Inst. 1998;90:1710–1719. doi: 10.1093/jnci/90.22.1710. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous